PTPRC and neoplasm: In association with the OCa tumor-killing effect of EC359, residual ID8 tumors in EC359-treated mice had massive infiltration of CD45+ leukocytes, which accounted for 75% of all live cells, as compared to only 5% in tumors in vehicle-treated mice (Fig. 6a, Supplementary Fig. 5a).